These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 33783763

  • 1. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
    Haranishi Y, Hara K, Terada T.
    Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
    [Abstract] [Full Text] [Related]

  • 2. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
    Borsani E, Labanca M, Bianchi R, Rodella LF.
    Brain Res; 2007 Jun 04; 1152():87-94. PubMed ID: 17459353
    [Abstract] [Full Text] [Related]

  • 3. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
    Rodella LF, Borsani E, Rezzani R, Ricci F, Buffoli B, Bianchi R.
    Eur J Pharmacol; 2005 Jan 31; 508(1-3):139-46. PubMed ID: 15680264
    [Abstract] [Full Text] [Related]

  • 4. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
    Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernández-Ruiz J, Barrett DA, Kendall DA, Chapman V.
    Eur J Neurosci; 2010 Apr 31; 31(8):1414-22. PubMed ID: 20384778
    [Abstract] [Full Text] [Related]

  • 5. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation.
    Sun L, Tai L, Qiu Q, Mitchell R, Fleetwood-Walker S, Joosten EA, Cheung CW.
    Eur J Pain; 2017 May 31; 21(5):804-814. PubMed ID: 28107590
    [Abstract] [Full Text] [Related]

  • 6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan 31; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 7. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N, Kostrzewa M, Makuch W, Pajak A, Kucharczyk M, Piscitelli F, Przewlocka B, Di Marzo V, Starowicz K.
    Pharmacol Res; 2016 Sep 31; 111():251-263. PubMed ID: 27326920
    [Abstract] [Full Text] [Related]

  • 8. Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain.
    Haranishi Y, Hara K, Terada T.
    Pharmacol Biochem Behav; 2020 Aug 31; 195():172964. PubMed ID: 32504731
    [Abstract] [Full Text] [Related]

  • 9. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.
    Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S.
    Eur J Neurosci; 2006 Oct 31; 24(7):2011-20. PubMed ID: 17040473
    [Abstract] [Full Text] [Related]

  • 10. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
    Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.
    PLoS One; 2013 Oct 31; 8(4):e60040. PubMed ID: 23573230
    [Abstract] [Full Text] [Related]

  • 11. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.
    Brain Res Mol Brain Res; 2004 Dec 06; 132(1):87-92. PubMed ID: 15548432
    [Abstract] [Full Text] [Related]

  • 12. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
    Mitchell VA, Greenwood R, Jayamanne A, Vaughan CW.
    Clin Exp Pharmacol Physiol; 2007 Nov 06; 34(11):1186-90. PubMed ID: 17880375
    [Abstract] [Full Text] [Related]

  • 13. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A, Okine BN, Finn DP, Masocha W.
    Biomed Pharmacother; 2020 Sep 06; 129():110456. PubMed ID: 32603895
    [Abstract] [Full Text] [Related]

  • 14. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
    Khasabova IA, Yao X, Paz J, Lewandowski CT, Lindberg AE, Coicou L, Burlakova N, Simone DA, Seybold VS.
    Pharmacol Res; 2014 Dec 06; 90():67-75. PubMed ID: 25304184
    [Abstract] [Full Text] [Related]

  • 15. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
    Schreiber AK, Neufeld M, Jesus CH, Cunha JM.
    Neuropharmacology; 2012 Dec 06; 63(8):1286-97. PubMed ID: 22959964
    [Abstract] [Full Text] [Related]

  • 16. CB1-cannabinoid-, TRPV1-vanilloid- and NMDA-glutamatergic-receptor-signalling systems interact in the prelimbic cerebral cortex to control neuropathic pain symptoms.
    Medeiros P, Oliveira-Silva M, Negrini-Ferrari SE, Medeiros AC, Elias-Filho DH, Coimbra NC, de Freitas RL.
    Brain Res Bull; 2020 Dec 06; 165():118-128. PubMed ID: 33038420
    [Abstract] [Full Text] [Related]

  • 17. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J.
    Neurobiol Dis; 2005 Nov 06; 20(2):207-17. PubMed ID: 16242629
    [Abstract] [Full Text] [Related]

  • 18. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV, Miguel CÁ, Soriano DB, Brumovsky PR, Villar MJ, Coronel MF.
    Exp Neurol; 2023 Jan 06; 359():114232. PubMed ID: 36179876
    [Abstract] [Full Text] [Related]

  • 19. Verbascoside administered intrathecally attenuates hyperalgesia via activating mu-opioid receptors in a rat chronic constriction injury model.
    Hara K, Haranishi Y, Terada T.
    Eur J Pain; 2022 Jul 06; 26(6):1322-1332. PubMed ID: 35437876
    [Abstract] [Full Text] [Related]

  • 20. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
    Liang YC, Huang CC, Hsu KS.
    Neuropharmacology; 2007 Jul 06; 53(1):169-77. PubMed ID: 17572451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.